“The American Society of Clinical Oncology (ASCO) applauds the Centers for Medicare & Medicaid Services (CMS) for taking a critical step toward transitioning Medicare from volume-based reimbursement to a system that emphasizes high-quality, patient-centered care. In today’s release of the MACRA Quality Payment Program (QPP), CMS has demonstrated welcomed flexibility and choices for clinicians.
We are particularly encouraged that CMS has introduced a QPP transitional period for 2017 and has included the general oncology specialty measure set in the final rule after removing it from the proposed rule. We are also very pleased to see special considerations being given to small and rural practices, which will help ensure that care for vulnerable patients with cancer will not be disrupted during this period of transition.
ASCO commends CMS for listening and responding to the feedback it received from across the medical community, and for making substantive changes that will reduce reporting burden and facilitate transition to alternative payment models. We will closely review the details of the final rule and offer a detailed analysis of the rule for our members."